| NDC Code | 54741-102-01 |
|---|
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (54741-102-01) |
|---|
| Product NDC | 54741-102 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Lamivudine And Zidovudine |
|---|
| Non-Proprietary Name | Lamivudine And Zidovudine |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20180419 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA206375 |
|---|
| Manufacturer | Shanghai Desano Bio-Pharmaceutical Co., Ltd. |
|---|
| Substance Name | LAMIVUDINE; ZIDOVUDINE |
|---|
| Strength | 150; 300 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|